Table 2.
Membrane | Materials core | Drug-loading | Research approaches | Ref. |
---|---|---|---|---|
Cancer cell membrane | Gold nanocage | Dox | In vivo and in vitro | [24] |
Cancer cell membrane | PLGA | None | In vivo and in vitro | [26] |
Cancer cell membrane | (Si–Pc)/PLNPs/hSiO2 | Dox | In vivo and in vitro | [7] |
Cancer cell membrane | ICG/PLGA | Fluorescent dyes | In vivo and in vitro | [27] |
Cancer cell membrane | PCL/F68 | PTX | In vivo and in vitro | [28] |
Cancer cell membrane | Hb/PLGA | Dox | In vivo and in vitro | [29] |
Cancer cell membrane | Fluorescent nanoprobes | Fluorescent dyes | In vivo and in vitro | [30] |
Cancer cell membrane | UCNPs | None | In vivo | [31] |
Red blood-cell membrane | PLGA | GA | In vivo and in vitro | [35] |
Erythrocyte membrane | UCNPs | Photosensitizer | In vivo and in vitro | [36] |
Erythrocyte membrane | Gold nanorods | Cyclopamine | In vivo and in vitro | [6] |
Red blood-cell membrane | Polypyrrole nanoparticles | BQ123 | In vivo and in vitro | [37] |
Leukocyte membrane | Nanoporous silicon particles | None | In vivo and in vitro | [39] |
Natural killer cell membrane | None | Dox | In vivo and in vitro | [47] |